Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma

Molecular Medicine Reports

Volumn 3, Issue 2, 2010, Pages 275-279

  Ha, Eun Young ^a   Bang, Ji Hye ^a   Son, Jung Nam ^a   Cho, Ho Chan ^b   Mun, Kyo Chul ^a  

^a Keimyung University School of Medicine   (South Korea)

^b Department of Family Medicine Daegu Medical Center   (South Korea)

Author keywords

Albumin; Carbamylation; MicroRNA; Renal cell carcinoma

Indexed keywords

ALBUMIN; MICRORNA; RNA; TRINITROBENZENESULFONIC ACID;

ADULT; ANIMAL CELL; ARTICLE; CANCER TISSUE; CARBAMOYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MESANGIUM CELL; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

RATTUS;

EID: 77950829527     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_000000251     Document Type: Article

References (25)

1. Erill S, Calvo R and Carlos R: Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther 27: 612-618, 1980.
2. Fluckiger R, Harmon W, Meier W, Loo S and Gabbay KH: Hemoglobin carbamylation in uremia. N Engl J Med 304: 823-827, 1981.
3. Hörkkö S, Huttunen K, Kervinen K and Kesäniemi YA: Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein. Eur J Clin Invest 24: 105-113, 1994.
4. Kraus LM and Kraus AP Jr: Carbamoylation of amino acids and proteins in uremia. Kidney Int 78: S102-S107, 2001.
5. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA and Hazen SL: Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13: 1176-1184, 2007.
6. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004.
8. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310: 1817-1821, 2005.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
10. Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA and Bloomfield CD: MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1919-1928, 2008.
11. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschl T: Identification of virus-encoded microRNAs. Science 304: 734-736, 2004.
12. Jaisson S, Delevallée-Forte C, Touré F, Rieu P, Garnotel R and Gillery P: Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst. FEBS Lett 581: 1509-1513, 2007.
13. Hörkkö S, Savolainen MJ, Kervinen K and Kesäniemi YA: Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int 41: 1175-1181, 1992.
14. Tate EW: Recent advances in chemical proteomics: exploring the post-translational proteome. J Chem Biol 1: 17-26, 2008.
15. Oimomi M, Ishikawa K, Kawasaki T, Hatanaka H, Ishikawa K, Kawasaki T, Yoshimura Y and Baba S: Carbamylated plasma protein in renal failure. Nippon Jinzo Gakkai Shi 28: 269-271, 1986.
16. Ok E, Basnakian AG, Apostolov EO, Barri YM and Shah SV: Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int 68: 173-178, 2005.
17. Kraus LM, Gaber L, Handorf CR, Marti HP and Kraus AP Jr: Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage. Swiss Med Wkly 24: 139-145, 2001.
18. Mun KC and Golper TA: Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif 18: 13-17, 2000.
19. Jaisson S, Larreta-Garde V, Bellon G, Hornebeck W, Garnotel R and Gillery P: Carbamylation differentially alters type I collagen sensitivity to various collagenases. Matrix Biol 26: 190-196, 2007.
20. G arnotel R, Sabbah N, Jaisson S and Gillery P: Enhanced activation and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen. FEBS Lett 563: 13-16, 2004.
21. Jaisson S, Lorimier S, Ricard-Blum S, Sockalingum GD, Delevallée-Forte C, Kegelaer G, Manfait M, Garnotel R and Gillery P: Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils. Chem Biol 13: 149-159, 2006.
22. Shaykh M, Pegoraro AA, Mo W, Arruda JA, Dunea G and Singh AK: Carbamylated proteins activate glomerular mesangial cells and stimulate collagen deposition. J Lab Clin Med 133: 302-308, 1999.
23. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC and Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
24. Taganov KD, Boldin MP, Chang KJ and Boltimore D: NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006.
25. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69: 1279-1283, 2009.